FIELD: medicine.
SUBSTANCE: uterine arteries are embolised, and methotrexate is administered intra-arterially, while a gestational sac is evacuated with a vacuum excochleator assisted with a transabdominaal ultrasonography. The uterine arteries are embolised using Embosphere® and HepaSphere™ microspheres. Methotrexate is administered intra-arterially from a primary blood supply of the gestational sac in a dose of 25 mg with embolysate microparticles using HepaSphere™ microparticles.
EFFECT: method provides the complete block of the blood supply of the gestational sac ensured by the distal and reliable embolisation, the target action of methotrexate on trophoblast tissue that in turn enables reducing the length of vacuum aspiration of the gestational sac in two times, avoiding the potential development of life-threatening bleeding accompanying the gestational sac evacuation, reducing the side effects of the treatment, and preserving the patient's reproductive function and life.
3 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIFFERENTIAL ORGAN PRESERVATION TREATMENT OF CERVICAL PREGNANCY AND PREGNANCY IN UTERINE SCAR AFTER CAESAREAN SECTION, DEPENDING ON DATA OF INTEGRATED ULTRASOUND AND LEVELS OF HUMAN CHORIONIC GONADOTROPIN (VERSIONS) | 2015 |
|
RU2640191C2 |
METHOD FOR DIFFERENTIATED ORGAN-PRESERVING TREATMENT OF PROGRESSIVE FALLOPIAN PREGNANCY IN INTERSTITIAL SECTION OF FALLOPIAN TUBE DEPENDING ON DATA FROM INTEGRATED ULTRASOUND INSPECTION AND LEVEL OF HUMAN CHORIONIC GONADOTROPIN IN PLASMA OF PATIENT (VERSIONS) | 2016 |
|
RU2643108C2 |
VACUUM ASPIRATION OF THE FETAL EGG FROM THE INTERSTITIAL DEPARTMENT OF THE UTERINE TUBE THROUGH A MINI-INCUT ON THE UTERUS BY LAPAROSCOPIC ACCESS | 2021 |
|
RU2772101C1 |
METHOD FOR PREDICTION OF HYSTEROMYOMA REGRESSION | 2015 |
|
RU2596093C1 |
METHOD FOR TREATING CERVICAL PREGNANCY | 2006 |
|
RU2314095C1 |
METHOD OF TREATING CERVICAL CANCER USING CHEMOEMBOLISATION OF UTERINE ARTERIES WITH PLATINUM DRUGS | 2015 |
|
RU2583144C1 |
DIAGNOSTIC TECHNIQUE FOR PLACENTAL INSUFFICIENCY IN FEMALE PATIENTS SUFFERED UTERINE ARTERY EMBOLISATION FOR HYSTEROMYOMA | 2013 |
|
RU2533851C1 |
METHOD FOR DETERMINING NON-TARGET UTERINE ARTERY EMBOLIZATION | 2021 |
|
RU2768142C1 |
METHOD FOR CHOOSING A MEDICAL AID IN PATIENTS WITH EXTRAUTERINE PREGNANCY | 2021 |
|
RU2755389C1 |
METHOD FOR PREDICTION OF MYOMATOUS ASSEMBLY EXPULSION FOLLOWING UTERINE ARTERY EMBOLIZATION IN A PATIENT WITH UTERINE MYOMA | 2019 |
|
RU2701210C1 |
Authors
Dates
2014-04-27—Published
2013-02-13—Filed